With a market capitalization of over $800 billion, Eli Lilly (NYSE: LLY) is the largest pharmaceutical company in the world.

Ashkenazi was CFO at Lilly from 2021 until leaving the company this summer. Like Montarce, she joined Lilly in 2001. During ...

Forget Mounjaro: 1 Reason Investors Should Love Eli Lilly Stock Even More (Hint: I'm Not Talking About Zepbound) ...

Sold under the brand names Mounjaro and Zepbound, tirzepatide has been an incredible growth driver for Eli Lilly. In 2022 -- ...

Consistent in their evaluation, an analyst from JP Morgan keeps a Overweight rating on Eli Lilly with a target price of $1100 ...

Company is investing $2.8bn in two Irish plants to produce its in-demand weight loss drugs and a new Alzheimer’s therapy ...

With a new investment in its two manufacturing sites in Ireland, Eli Lilly continues implementing the largest expansion ...

As a part of this expansion, Lilly will create another 150 jobs for highly skilled workers in Limerick, bringing its total ...

Lucas Montarce succeeded Anat Ashkenazi, who left Lilly in late July to serve as CFO and SVP of Google and Alphabet.

This additional investment is part of the most ambitious manufacturing expansion agenda in the company's history. Since 2020, ...

Safe Stocks To Invest In Now. In this article, we are going to take a look at where Eli Lilly and Company (NYSE:LLY) stands ...

U.S. pharmaceutical giant Eli Lilly named a new chief financial officer on Monday during a critical time for the company's ...